- Last sale
- Nov 12, 2026 · -3.29%
- Market cap
- $1.59B
- 57.69M shares
- Filings
- 1,046
Q3 2026+6.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−24.5% FY25 yoy
- $1.59B
- —
- 0.7×
- 1.1×
- 4.36%
- —
Twelve months to Oct 2, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,248,049,000 | reported | |
| FY 2024 | 2024-12-31 | $2,107,623,000 | reported | |
| FY 2023 | 2023-12-31 | $1,707,197,000 | reported | |
| FY 2022 | 2022-12-31 | $1,563,101,000 | reported | |
| FY 2021 | 2021-12-31 | $1,426,188,000 revised | reported | |
| FY 2020 | 2020-12-31 | $1,120,700,000 revised | reported | |
| FY 2019 | 2019-12-31 | $3,327,458,000 | reported | |
| FY 2018 | 2018-12-31 | $2,193,083,000 revised | reported | |
| FY 2017 | 2017-12-31 | $1,937,282,000 revised | reported | |
| FY 2016 | 2016-12-31 | $3,185,753,000 revised | reported | |
| FY 2015 | 2015-12-31 | $3,434,352,000 revised | reported | |
| FY 2014 | 2014-12-31 | $4,624,476,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $3.50M | $3.50M | — | 57.25M sh | +0.5% | 17.6% |
| FY2024 | — | $4.77M | $4.77M | — | 56.96M sh | +4.3% | — |
| FY2023 | — | $0.00 | $0.00 | — | 54.62M sh | +0.5% | 0.0% |
| FY2022 | — | $0.00 | $0.00 | — | 54.33M sh | −66.3% | — |
| FY2020 | — | $0.00 | $0.00 | — | 118.55M sh | +0.3% | 0.0% |
Segments
LineFY2025ShareChange
Prevention & Recovery:$1.14B51%+3.6%
Reconstructive:$1.11B49%+10.0%
Fabrication Technology———
Total$2.25B
Orthopedic, prosthetic & surgical appliances & supplies
Enovis CORP is the 7th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 3842
CompanyRevenueGrowthNet marginMarket cap
ISRGIntuitive Surgical Inc$10.1B20.5%28.4%$152.5BZBHZimmer Biomet Holdings, Inc.$8.2B7.2%8.6%$19.8BSNNSmith & Nephew PLC$6.2B6.1%10.1%—EWEdwards Lifesciences Corp$6.1B11.5%17.7%$60.9BSTESteris PLC$5.9B8.7%13.2%$24.6BALGNAlign Technology Inc$4.0B0.9%10.2%$11.8B
ENOVEnovis CORP (this company)$2.2B6.7%52.7%$1.6B
MSAMSA Safety Inc$1.9B3.7%14.9%$6.7BCDRECadre Holdings, Inc.$610.3M7.5%7.2%$1.4BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Enovis CORP · CIK 1420800 · Engraved from SEC EDGAR